ES2385683A1 - Composiciones para el tratamiento del dolor y/o la inflamación. - Google Patents

Composiciones para el tratamiento del dolor y/o la inflamación. Download PDF

Info

Publication number
ES2385683A1
ES2385683A1 ES201031527A ES201031527A ES2385683A1 ES 2385683 A1 ES2385683 A1 ES 2385683A1 ES 201031527 A ES201031527 A ES 201031527A ES 201031527 A ES201031527 A ES 201031527A ES 2385683 A1 ES2385683 A1 ES 2385683A1
Authority
ES
Spain
Prior art keywords
inflammation
pain
treatment
compositions
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201031527A
Other languages
English (en)
Other versions
ES2385683B1 (es
Inventor
Cristina SERRAÏMA CARREÑO
Win Van Den Nest
Antonio Ferrer Montiel
María CAMPRUBÍ ROBLES
Jimena FERNÁNDEZ CARNEADO
Berta Ponsati Obiols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BCN Peptides SA
Original Assignee
DiverDrugs SL
BCN Peptides SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DiverDrugs SL, BCN Peptides SA filed Critical DiverDrugs SL
Priority to ES201031527A priority Critical patent/ES2385683B1/es
Publication of ES2385683A1 publication Critical patent/ES2385683A1/es
Application granted granted Critical
Publication of ES2385683B1 publication Critical patent/ES2385683B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones para el tratamiento del dolor y/o la inflamación que comprenden al menos un péptido de fórmula general (I) R1-AA-R2, sus estereoisómeros, mezclas de los mismos, y sus sales cosmética y farmacéuticamente aceptables, donde AA es una secuencia de 3 a 40 aminoácidos adyacentes contenida en la secuencia de aminoácidos de la proteína SNAP-25. Péptido de fórmula general (I), sus estereoisómeros, mezclas de los mismos, y sus sales cosmética y farmacéuticamente aceptables para el tratamiento del dolor y/o inflamación.
ES201031527A 2010-10-18 2010-10-18 Composiciones para el tratamiento del dolor y/o la inflamación. Active ES2385683B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201031527A ES2385683B1 (es) 2010-10-18 2010-10-18 Composiciones para el tratamiento del dolor y/o la inflamación.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201031527A ES2385683B1 (es) 2010-10-18 2010-10-18 Composiciones para el tratamiento del dolor y/o la inflamación.

Publications (2)

Publication Number Publication Date
ES2385683A1 true ES2385683A1 (es) 2012-07-30
ES2385683B1 ES2385683B1 (es) 2013-10-07

Family

ID=46489529

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201031527A Active ES2385683B1 (es) 2010-10-18 2010-10-18 Composiciones para el tratamiento del dolor y/o la inflamación.

Country Status (1)

Country Link
ES (1) ES2385683B1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2532749R1 (es) * 2013-09-30 2015-05-06 Universidad Miguel Hernández De Elche Péptidos bloqueantes de termorreceptores y sus usos

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180524A1 (en) * 1999-04-23 2002-02-20 Lipotec, S.A. Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
ES2322882A1 (es) * 2006-10-25 2009-06-30 Lipotec, S.A. Peptidos inhibidores de la exocitosis neuronal.
WO2010009892A2 (en) * 2008-07-24 2010-01-28 Bcn Peptides, S.A. Compositions for the treatment of pain and/or inflamation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180524A1 (en) * 1999-04-23 2002-02-20 Lipotec, S.A. Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
ES2322882A1 (es) * 2006-10-25 2009-06-30 Lipotec, S.A. Peptidos inhibidores de la exocitosis neuronal.
WO2010009892A2 (en) * 2008-07-24 2010-01-28 Bcn Peptides, S.A. Compositions for the treatment of pain and/or inflamation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2532749R1 (es) * 2013-09-30 2015-05-06 Universidad Miguel Hernández De Elche Péptidos bloqueantes de termorreceptores y sus usos

Also Published As

Publication number Publication date
ES2385683B1 (es) 2013-10-07

Similar Documents

Publication Publication Date Title
ES2356883A1 (es) Composicion para el tratamiento del dolor y/o la inflamacion.
CO6430467A2 (es) Péptidos útiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosméticas o farmacéuticas
MX2021006421A (es) Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17).
BR112017012474A2 (pt) composto peptídico, composição cosmética ou dermofarmacêutica, uso de pelo menos um composto peptídico, e, método para aumentar a atividade na síntese de macromoléculas do ecm da pele de um composto peptídico.
BR112015001419A8 (pt) composto, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo
ECSP19025350A (es) Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi)
ECSP13012658A (es) Composiciones y métodos para el tratamiento de la mielofibrosis
BR112015009037A2 (pt) composição farmacêutica para uso no tratamento de infarto do miocárdio e uso de um peptídeo de fragmento de hmgb1
BR112013031268A8 (pt) polipeptídeos
DOP2011000264A (es) Derivados de aminotetralina, composiciones farmaceuticas que los contienen y sus usos en terapia
CL2013002737A1 (es) Acido 4-((4-((((1r, 2s)-2-fenilciclopropil)amino)metil)piperidin-1-il)metil)benzoico con actividad inhibidora de desmetilasa 1 especifica de lisina (lsd1); composicion farmaceutica que lo comprende, utiles en el tratamiento del cancer.
CO6351742A2 (es) Compuestos organicos para la cicatrizacion de heridas
EA201270824A1 (ru) Соединения для уменьшения продукции бета-амилоида
ES2397889A1 (es) PÉPTIDOS MODULADORES DE PGC-1Alfa.
BR112015006828A8 (pt) composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; uso do composto; e método para modular a atividade de uma proteína ire1
CL2011000306A1 (es) Compuestos derivados de di-alquilamida del acido 7-ciclopentil-2-[5-(piperidin o piperazin sustituido)-piridin-2-il amino]-7h-pirrolo-[2,3-d]-pirimidin-6-carboxilico, inhibidores de cdk4; composicion farmaceutica; y su uso para el tratamiento del cancer o la inflamacion.
BR112012029975A2 (pt) peptídeo como medicamento, em particular para o tratamento do câncer.
MX2024006689A (es) Sales monoacidas de 6-aminoisoquinolinas y usos de las mismas.
UY35455A (es) Inhibidores tripeptidicos de la epoxicetona proteasa
CO6592101A2 (es) Metodos para tratar ulceras de pie de diabetico
BR112012015984A2 (pt) composição para melhorar a função cerebral, e, polipeptídeo
AR087902A1 (es) COMPOSICIONES Y METODOS PARA TRATAR EL CANCER USANDO EL INHIBIDOR DE PI3Kb Y EL INHIBIDOR DE LA VIA DE MAPK, INCLUIDOS LOS INHIBIDORES DE MEK Y RAF
BR112016003082A8 (pt) uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida
UY33568A (es) Compuestos que interactuan con proteina reguladora de glucocinasa para el tratamiento de diabetes.
AR093717A1 (es) Composiciones y metodos para el tratamiento de la caries dental

Legal Events

Date Code Title Description
PC2A Transfer of patent

Owner name: BCN PEPTIDES, S.A.

Effective date: 20120905

FG2A Definitive protection

Ref document number: 2385683

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20131007